1-3 of 3
Nihad Mokhtar
Close
Sort by
Journal Articles

Real World Efficacy of the Novel Chemo-Free Combination of Brentuximab Vedotin Plus Nivolumab (BvNivo) in Patients with Relapsed/Refractory Hodgkin Lymphoma. Single Center Experience

Abdulelah Al Shami, Zakiah Al Somali, Asma Al Ismail, Hussain Al Yusif, Mohammed Darweesh, Nihad Mokhtar, Manar Abdulbaqi, Jenifer Bacal, Ayed Garni, Abdulrahman Naim, Fahad Al Rowais, Solaf Kanfar, John Apostolidis
Journal: Blood
Blood (2022) 140 (Supplement 1): 12038–12039.
https://doi.org/10.1182/blood-2022-167010
Published: 2022
Journal Articles

Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials

Mohammed Kawari, Mahmood Akhtar, Mohamed Sager, Zakaria Basbous, Ibrahim Baydoun, Juma Kabanja, Mohammed Darweesh, MD, Nihad Mokhtar, MD, Solaf Kanfar, MD, Enas Mutahar, MD, John Apostolidis, MD, Khalid Ahmed Al-Anazi, MD, Hani Al Hashmi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5455.
https://doi.org/10.1182/blood-2019-121643
Published: 2019
Journal Articles

Excellent Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Eastern Province of Saudi Arabia. a Real-World Case Series of 49 Consecutive Patients Treated at a Referral Center from 2006 to 2017

John Apostolidis, MD MSc MD(res), Nihad Mokhtar, MD, Mohammed Darweesh, MD, Enas Mutahar, MD, Manar Abdulbaqi, MD, Salman Harbi, MD, Eshrak Shaibani, MD, Mohammed Kawari, MD, Ayman Abulhassan, MD, Jenifer Bacal, Heba Raslan, MD, Afrah Dawood, MD, Asif Moinuddid, MD, Ahmed Buali, MD, Eman Debawy, MD, Taghreed Hindi, MD, Ayed Garni, MD, Mohammed Rahal, MD, Panagiotis Kaloyannidis, MD, Khalid Anezi, MD, Hani Hassan Al Hashmi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5365.
https://doi.org/10.1182/blood-2018-99-113279
Published: 2018